Generic placeholder image

Recent Patents on Inflammation & Allergy Drug Discovery


ISSN (Print): 1872-213X
ISSN (Online): 2212-2710

Anaphylaxis: An Update on its Understanding and Management

Author(s): Cristoforo Incorvaia, Marina Mauro, Valerio Pravettoni, Stefano Incorvaia and Gian G. Riario-Sforza

Volume 4, Issue 2, 2010

Page: [124 - 129] Pages: 6

DOI: 10.2174/187221310791163107

Price: $65


Anaphylaxis is the most concerning manifestation of hypersensitivity. Recent, thorough investigations on the pathophysiology of anaphylaxis achieved important advances in its understanding, regarding in particular the emerging role of mediators such as platelet activating factor (PAF) and sphyngosine 1 phosphate (S1P) and the improved knowledge on the actors of the signaling cascade, from the contact between the specific allergen and the IgE fixed on the Fc-epsilon-RI receptor to the opening of calcium channels. These advances may provide new diagnostic and therapeutical tools. In particular, a role for PAF and S1P as laboratory markers of anaphylaxis is likely to be developed, and innovative preventive strategies able to induce a negative signaling are currently under evaluation. Also, using well known preventive treatments, such as allergen specific immunotherapy may offer new perspectives for the management of patients at risk of potentially fatal reaction to foods. In fact, controlled studies demonstrated that sublingual immunotherapy is able to significantly increase the tolerance to the causative foods, fulfilling the need and protecting the allergic subject from anaphylaxis caused by accidental ingestion of small food amounts. The article also presented some promising patents on anaphylaxis.

Keywords: Anaphylaxis, mast cells, signaling cascade, mediators, PAF, S1P, tryptase, epinephrine, sublingual immunotherapy, anti-IgE

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy